Prebiotics: A New Frontier in Treating Inflammatory Bowel Disease

An increasing amount of research indicates that altering gut bacteria could be a viable strategy for treating inflammatory bowel disease (IBD), a persistent and severe condition that impacts millions globally.

IBD, encompassing Crohn’s disease, ulcerative colitis, and unclassified IBD, is characterized by chronic inflammation of the digestive tract. Conventional treatments aim to control symptoms and prevent complications. However, they often have limited effectiveness and can come with side effects.